Breast cancer cells usually secrete matrix-associated proteases, such as matrix metalloproteinases (MMPs) and urokinase activator of plasminogen (uPA) to degrade the ECM which means attenuating the expression and activity of MMPs (48) and uPA (49) is also responsible for inhibiting breast cancer cell invasion and metastasis (45). Here, PLAU is linked to breast cancer.